Timing of multikinase inhibitor initiation in differentiated thyroid cancer

There are limited treatment options for patients with radioactive iodine refractory, progressive differentiated thyroid cancer. Although there is consensus that multikinase inhibitor therapy should be considered in patients with progressive disease with considerable tumor load or symptomatic disease...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Endocrine-related cancer 2017-05, Vol.24 (5), p.237-242
Hauptverfasser:	Brose, Marcia S, Smit, Johannes, Lin, Chia-Chi, Pitoia, Fabian, Fellous, Marc, DeSanctis, Yoriko, Schlumberger, Martin, Tori, Masayuki, Sugitani, Iwao
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Carcinoma - drug therapy Carcinoma - pathology Carcinoma - radiotherapy Drug Administration Schedule Editor's Choice Female Humans Iodine Radioisotopes - therapeutic use Male Middle Aged Niacinamide - analogs & derivatives Niacinamide - therapeutic use Phenylurea Compounds - therapeutic use Protein Kinase Inhibitors - administration & dosage Protein Kinase Inhibitors - adverse effects Quinolines - therapeutic use Salvage Therapy Thyroid Neoplasms - drug therapy Thyroid Neoplasms - pathology Thyroid Neoplasms - radiotherapy Time Factors Treatment Failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!